Genetic basis of atrial fibrillation

Current Opinion in Cardiology

Volumn 29, Issue 3, 2014, Pages 220-226

  Hong, Kui ^a   Xiong, Qinmei ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

atrial fibrillation; gene; genetic testing

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GAP JUNCTION PROTEIN; ION CHANNEL; NUCLEOPORIN; RYANODINE RECEPTOR 2; T BOX TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; MUTATION; PATHOPHYSIOLOGY; PHARMACOGENETICS; RISK ASSESSMENT;

ATRIAL FIBRILLATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTATION; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; RISK ASSESSMENT;

EID: 84899482821     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000051     Document Type: Review

References (60)

1. Hobbs FD, Fitzmaurice DA, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005; 9:1-74.
2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114:119-125.
3. Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336:905-911.
4. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003; 299:251-254.
5. Hong K, Piper DR, Diaz-Valdecantos A, et al. De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 2005; 68:433-440.
6. Lundby A, Ravn LS, Svendsen JH, et al. KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm 2007; 4:1532-1541.
7. Ritchie MD, Rowan S, Kucera G, et al. Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. J Am Coll Cardiol 2012; 60:1173-1181.
8. Bartos DC, Duchatelet S, Burgess DE, et al. R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation. Heart Rhythm 2011; 8:48-55.
9. Makiyama T, Akao M, Shizuta S, et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 2008; 52:1326-1334.
10. Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005; 293:447-454.
11. Ellinor PT, Nam EG, Shea MA, et al. Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm 2008; 5:99-105.
12. Olesen MS, Yuan L, Liang B, et al. High prevalence of long QT syndromeassociated SCN5A variants in patients with early-onset lone atrial fibrillation. Circ Cardiovasc Genet 2012; 5:450-459.
13. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004; 109: 30-35.
14. Yang Y, Xia M, Jin Q, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004; 75:899-905.
15. Zhang DF, Liang B, Lin J, et al. KCNE3 R53H substitution in familial atrial fibrillation. Chin Med J (Engl) 2005; 118:1735-1738.
16. Lundby A, Ravn LS, Svendsen JH, et al. KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol Biochem 2008; 21:47-54.
17. Ravn LS, Aizawa Y, Pollevick GD, et al. Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm 2008; 5:427-435.
18. Xia M, Jin Q, Bendahhou S, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 2005; 332:1012-1019.
19. Priori SG, Pandit SV, Rivolta I, et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 2005; 96:800-807.
20. Deo M, Ruan Y, Pandit SV, et al. KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia. Proc Natl Acad Sci USA 2013; 110:4291-4296.
21. Yang Y, Li J, Lin X, et al. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet 2009; 54:277-283.
22. Olson TM, Alekseev AE, Liu XK, et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 2006; 15:2185-2191.
23. Yang T, Yang P, Roden DM, et al. Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation. Heart Rhythm 2010; 7:1246-1252.
24. Olson TM, Alekseev AE, Moreau C, et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med 2007; 4:110-116.
25. Watanabe H, Darbar D, Kaiser DW, et al. Mutations in sodium channel beta1-and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2009; 2:268-275.
26. Olesen MS, Jespersen T, Nielsen JB, et al. Mutations in sodium channel betasubunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res 2011; 89:786-793.
27. Wang P, Yang Q, Wu X, et al. Functional dominant-negative mutation of sodium channel subunit gene SCN3B associated with atrial fibrillation in a Chinese GeneID population. Biochem Biophys Res Commun 2010; 398:98-104.
28. Li RG, Wang Q, Xu YJ, et al. Mutations of the SCN4B-encoded sodium channel beta4 subunit in familial atrial fibrillation. Int J Mol Med 2013; 32:144-150.
29. Zhabyeyev P, Hiess F, Wang R, et al. S4153R is a gain-of-function mutation in the cardiac Ca(2\+) release channel ryanodine receptor associated with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation. Can J Cardiol 2013; 29:993-996.
30. Kazemian P, Gollob MH, Pantano A, et al. A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by beta-blocker therapy. Can J Cardiol 2011; 27:870-877.
31. Bhuiyan ZA, van den Berg MP, van Tintelen JP, et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation 2007; 116:1569-1576.
32. Huang RT, Xue S, Xu YJ, et al. A novel NKX2.5 loss-of-function mutation responsible for familial atrial fibrillation. Int J Mol Med 2013; 31:1119-1126.
33. Abraham RL, Yang T, Blair M, et al. Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. J Mol Cell Cardiol 2010; 48:181-190.
34. Hodgson-Zingman DM, Karst ML, Zingman LV, et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 2008; 359:158-165.
35. Zhang X, Chen S, Yoo S, et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 2008; 135:1017-1027.
36. Postma AV, van de Meerakker JB, Mathijssen IB, et al. A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res 2008; 102:1433-1442.
37. Thibodeau IL, Xu J, Li Q, et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 2010; 122:236-244.
38. Gollob MH, Jones DL, Krahn AD, et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006; 354:2677-2688.
39. Sun Y, Yang YQ, Gong XQ, et al. Novel germline GJA5/connexin40 mutations associated with lone atrial fibrillation impair gap junctional intercellular communication. Hum Mutat 2013; 34:603-609.
40. Shi HF, Yang JF, Wang Q, et al. Prevalence and spectrum of GJA5 mutations associated with lone atrial fibrillation. Mol Med Rep 2013; 7:767-774.
41. Beavers DL, Wang W, Ather S, et al. Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. J Am Coll Cardiol 2013; 62:2010-2019.
42. Yang YQ, Xu YJ, Li RG, et al. Prevalence and spectrum of PITX2c mutations associated with familial atrial fibrillation. Int J Cardiol 2013; 168:2873-2876.
43. Zhou YM, Zheng PX, Yang YQ, et al. A novel PITX2c loss-of-function mutation underlies lone atrial fibrillation. Int J Mol Med 2013; 32:827-834.
44. Yang YQ, Wang MY, Zhang XL, et al. GATA4 loss-of-function mutations in familial atrial fibrillation. Clin Chim Acta 2011; 412:1825-1830.
45. Yang YQ, Wang J, Wang XH, et al. Mutational spectrum of the GATA5 gene associated with familial atrial fibrillation. Int J Cardiol 2012; 157:305-307.
46. Yang YQ, Li L, Wang J, et al. GATA6 loss-of-function mutation in atrial fibrillation. Eur J Med Genet 2012; 55:520-526.
47. Lü bkemeier I, Machura K, Kurtz L, et al. The connexin 40 A96S mutation causes renin-dependent hypertension. J Am Soc Nephrol 2011; 22:1031-1040.
48. Yang YQ, Gharibeh L, Li RG, et al. GATA4 loss-of-function mutations underlie familial tetralogy of fallot. Hum Mutat 2013; 34:1662-1671.
49. Xiao P, Ling Z, Woo K, et al. Renin-angiotensin system-related gene polymorphisms are associated with risk of atrial fibrillation. Am Heart J 2010; 160:496-505.
50. Wang QS, Li YG, Chen XD, et al. Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese. J Electrocardiol 2010; 43:373-377.
51. Olesen MS, Holst AG, Jabbari J, et al. Genetic loci on chromosomes 4q25, 7p31, and 12p12 are associated with onset of lone atrial fibrillation before the age of 40 years. Can J Cardiol 2012; 28:191-195.
52. Ellinor PT, Lunetta KL, Albert CM, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012; 44:670-675.
53. Darbar D, Motsinger AA, Ritchie MD, et al. Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. Heart Rhythm 2007; 4:743-749.
54. Parvez B, Vaglio J, Rowan S, et al. Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. J Am Coll Cardiol 2012; 60:539-545.
55. Lombardi F, Belletti S, Battezzati PM, et al. MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation. J Cardiovasc Med (Hagerstown) 2011; 12:37-42.
56. Husser D, Adams V, Piorkowski C, et al. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2010; 55: 747-753.
57. Wutzler A, Kestler C, Perrot A, et al. Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2013; 168:3647-3651.
58. Lubitz SA, Yin X, Fontes JD, et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA 2010; 304:2263-2269.
59. Arnar DO, Thorvaldsson S, Manolio TA, et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006; 27:708-712.
60. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8:1308-1339.